Cheer on reciprocal tariffs! Donald Trump spares India’s pharmaceutical industry
US President Trump has exempted Indian pharmaceuticals from new reciprocal tariffs, benefiting India's pharmaceutical sector. This sector is vital for affordable medicines and economic stability, with the US market representing 30% of Indian exports.
US President Trump has exempted Indian pharmaceuticals from new reciprocal tariffs, benefiting India's pharmaceutical sector. This sector is vital for affordable medicines and economic stability, with the US market representing 30% of Indian exports.
